Tuesday 28 September 2021

Cuban Drug to Treat Lung Cancer Presented in Colombia

Paying the bills

Latest

Can tourists get vaccinated in Costa Rica?

QCOSTARICA - Can tourists be vaccinated in Costa Rica,...

Today’s Vehicle Restriction September 28: Plates ending in “3 & 4” CANNOT circulate

QCOSTARICA - For today, Tuesday, September 28, vehicles with...

Mexico reveals why it rejects tourists from Costa Rica

QCOSTARICA - Mexico has been one of the favorite...

Bianca, Mick Jagger’s first wife: “Nicaraguan by grace of God”

QCOSTARICA - Bianca Jagger, who was the first wife...

Train Yourself to Stay Calm Under Pressure

Do you know anyone who handles stress really well?...

Alunasa, a Venezuelan state company in Costa Rica, leaves employees without salary

QCOSTARICA - The Venezuela state-owned company operating in Costa...

In Venezuela there is food, but expensive

Q24N - The Venezuelan economy has begun to reactivate....
Paying the bills

Share

The Cuban vaccine to treat lung cancer, known as Cimavax
The Cuban vaccine to treat lung cancer, known as Cimavax

(Today Colombia) The Cuban vaccine to treat lung cancer, known as Cimavax, was presented to a group of experts attending the First International Symposium on Active Immunotherapy, hosted in Medellin, Colombia over the weekend.

The drug was developed in Cuba by the Center of Molecular Immunology and has been successful used to treat patients with advanced lung cancer.

The drug, considered a scientific achievement was developed over two decades in Cuba and has already been registered at the National Food and Drug Surveillance Institute in Colombia (INVIMA).

- Advertisement -

After presenting the medicine in the South American country, Cimavax could be marketed in the nation’s hospital network.

One of the great advantages of Cimavax is that it does not have side effects, as chemotherapy does, this was explained to the delegates from the different countries attended the scientific event in Medellin on Saturday and Sunday.

Cuban doctor, Tania Crombet, a specialist in Immunology and Doctor of the Higher Institute of Medical Sciences of Havana Sciences, presented the vaccine.

Dr. Kelvin Lee, Chair of the Department of Immunology at the Roswell Park Cancer Institute, and Dr. K. Govind Babu, MBBS in cancer medicine, with 26 years of experience in this field, were present during the presentation of the vaccine.

The drug allows the prolongation of life for up to five years, something almost unthinkable for those suffering from the disease in its advanced stage, until now the survival rate did not exceed 18 months.

- Advertisement -

Article originally appeared at Today Colombia. Reposted with permission.

- Advertisement -
Paying the bills
Q24N
Q24N is an aggregator of news for Latin America. Reports from Mexico to the tip of Chile and Caribbean are sourced for our readers to find all their Latin America news in one place.

Related Articles

Subscribe to our stories

To be updated with all the latest news, offers and special announcements.

Article originally appeared at Today Colombia. Reposted with permission.

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.